| 1.43 Data as of 4:00pm ET |  0.00 / 0.00%Today’s Change | 0.42 Today|||52-Week Range 1.96 | +31.19% Year-to-Date |
| Previous close | 1.43 |
| Today’s open | 1.44 |
| Day’s range | 1.40 - 1.48 |
| Volume | 805,124 |
| Average volume (3 months) | 432,544 |
| Market cap | $98.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +34.62% |
| Earnings growth (this year) | -2.94% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +4.37% |
| P/E ratio | NM |
| Price/Sales | 155.47 |
| Price/Book | 13.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| AGENAgenus Inc | +0.02 | +0.50% |
| BCRXBioCryst Pharmaceuti... | -0.02 | -1.18% |
| PIPPharmAthene Inc | -0.00 | -0.30% |
| CYTRCytRx Corp | -0.11 | -4.55% |
| Last reporting date | May 17, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $407.7K |
| Annual profit (last year) | -$10.1M |
| Net profit margin | -2,482.54% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientific Officer Karl Y. Johe, PhD |
President, CEO, CFO, Director & Legal Counsel I. Richard Garr |
Corporate headquarters Rockville, Maryland |
.
